Hormone finding could lead to diabetes cure

Korean scientists have discovered the role of a hormone that could help develop medicines to treat and cure diabetes and obesity-associated diseases.

Dr. Lee Myung-sik of Samsung Medical Center, who is also a professor at Sungkyunkwan University School of Medicine, led a study into “mitokine” signals, which are sent by cells having trouble with their metabolism. They identified that the signal involved a hormone, encoded as the fibroblast growth factor 21, or FGF21. The hormone is induced by mitochondria, which generate energy for cells.

Yuan Zhang, a postdoctoral fellow at the University of Texas Southwestern Medical Center Department of Pharmacology, called FGF21 the “starvation hormone” in an Oct. 15 report, saying that it boosts the lifespan of laboratory mice and increases insulin sensitivity.

For full article see Korea Herald.